Keisuke Nagai

Title: Keisuke Nagai: Innovator in D-Dimer Assaying Technology

Introduction

Keisuke Nagai is a prominent inventor based in Kobe, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the development of reagents for assaying D-dimer. With a total of 2 patents to his name, Nagai's work has the potential to enhance the accuracy and efficiency of D-dimer testing.

Latest Patents

Nagai's latest patents focus on a reagent for assaying D-dimer and a corresponding kit. The invention provides a reagent that includes carriers sensitized to first and second monoclonal antibodies that react with D-dimer. These antibodies exhibit different reactivity to D-dimer, where the first monoclonal antibody reacts with both high- and low-molecular fractions of D-dimer. In contrast, the second monoclonal antibody specifically reacts with the high-molecular fraction, demonstrating a different reactivity with the low-molecular fraction compared to the first monoclonal antibody. This innovative approach aims to improve the reliability of D-dimer assays.

Career Highlights

Keisuke Nagai is currently associated with Sysmex Corporation, a leading company in the field of medical diagnostics. His work at Sysmex has allowed him to focus on advancing diagnostic technologies that can significantly impact patient care.

Collaborations

Nagai has collaborated with notable colleagues, including Kazuaki Yamashita and Susumu Hoshiko. These collaborations have contributed to the development of innovative solutions in the field of diagnostics.

Conclusion

Keisuke Nagai's contributions to D-dimer assaying technology exemplify the importance of innovation in medical diagnostics. His patents and work at Sysmex Corporation highlight his commitment to improving healthcare outcomes through advanced diagnostic tools.